wilate 1000 1000 ui fvw/1000 ui fviii
octapharma pharmazeutika produktionsges.m.b.h. - austria - factorul viii de coagulare dacĂ factorul von willebrand - pulb.+solv. pt. sol. inj. - 1000 ui fvw/1000 ui fviii - vitamina k si alte hemostatice factori ai coagularii sanguine
aflubin picături orale, soluţie
richard bittner ag - combinaţie - picături orale, soluţie
zynlonta
swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - agenți antineoplazici - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.
flixotide suspensie de inhalat presurizata 125 mcg/doza
glaxo wellcome uk ltd - fluticasonum - suspensie de inhalat presurizata - 125 mcg/doza
flixotide suspensie de inhalat presurizata 50 mcg/doza
glaxo wellcome uk ltd - fluticasonum - suspensie de inhalat presurizata - 50 mcg/doza
flixotide 125 inhaler cfc - free
glaxo wellcome uk ltd. - fluticasonum propionat - susp. inhal. presurizata - 125µg/doza - alte med. pt. trat. bolilor obstructive ale c.r, inhalatorii glucocorticoizi
flixotide 250 inhaler cfc - free
glaxo wellcome uk ltd. - fluticasonum propionat - susp. inhal. presurizata - 250µg/doza - alte med. pt.trat. bolilor obstructive ale c.r, inhalatorii glucocorticoizi
flixotide nebules 2 mg/2 ml
glaxo wellcome uk limited - fluticasonum propionat - susp. inhal. prin nebulizator - 2mg/2ml - alte med. pt.trat. bolilor obstructive ale c.r, inhalatorii glucocorticoizi
flixotide nebules 0,5 mg/2 ml
glaxo wellcome uk limited - fluticasonum propionat - susp. inhal. prin nebulizator - 0,5mg/2ml - alte med. pt. trat.bolilor obstructive ale c.r, inhalatorii glucocorticoizi
flixotide diskus 100 micrograme
glaxo wellcome uk limited - fluticasonum propionat - pulb. inhal. - 100micrograme - alte med. pt.trat.bolilor obstructive ale c.r, inhalatorii glucocorticoizi